Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ronnie van der Holt"'
Autor:
Myriam Labopin, Nicole Raus, Régis Peffault de Latour, Mohamad Mohty, Katharina Fleischhauer, Gérard Socié, Daniel Hanau, Nicolas Jung, Ibrahim Yakoub-Agha, Xavier Lafarge, Miriam Hoffmann, Raphael Carapito, Jordi Sierra, Philippe Moreau, Anne Cesbron, Masao Ota, Seiamak Bahram, Arnon Nagler, A. Parissiadis, Mauricette Michallet, Ryad Tamouza, Franz Claas, Gaëlle Giacometti, Myriam Labalette, Ronnie van der Holt, Pascale Loiseau, Fabio Ciceri, Didier Blaise, Eric Spierings, Meiggie Untrau, Valérie Dubois, Catherine Paillard, Luca Vago, Noel Milpied, Antoine Toubert, Hidetoshi Inoko, Sergio Querol, Christophe Picard, Angélique Pichot, Dominique Charron, Sandra Michel, Katia Gagne, Bruno Lioure, Machteld Oudshoorn
Publikováno v:
Blood
Blood, American Society of Hematology, 2014, 124 (21), ⟨10.1182/blood.V124.21.664.664⟩
ResearcherID
Web of Science
Blood, American Society of Hematology, 2014, 124 (21), ⟨10.1182/blood.V124.21.664.664⟩
ResearcherID
Web of Science
Background: Graft-versus-host disease (GVHD) is a major cause of mortality after unrelated hematopoietic stem cell transplantations (HSCT). Despite the development of modern immunosuppressive strategies, a nearly perfectly controlled compatibility of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aee6624066d8d18361b8a19a9e477717
Autor:
Charles J. Vecht, Peter A. E. Sillevis Smitt, Anna Tsafka, Erna Elfrink, Ineke Elswijk-de Vries, Martin J. van den Bent, Ronnie van der Holt, Frederique Teng-van de Zande
Publikováno v:
Cancer, 83, 2015-2022. John Wiley & Sons Inc.
BACKGROUND Some cancer patients require invasive techniques for control of chronic cancer pain. Many patients have benefited from local administration of opioids and anesthetics through an epidural catheter. However, epidural abscess and meningitis a
Autor:
Okke de Weerdt, Marleen Luten, René van der Griend, Anneke Brand, Ronnie van der Holt, Peter A. W. te Boekhorst, Jaap Jan Zwaginga, Sonja Zweegman, Art Vreughdenhil, Elisabeth C. M. Van Pampus, Bart J. Biemond, P. C. Huijgens, Mark Levin, Harry R. Koene, Rene Hollestein, Hans Pruijt
Publikováno v:
Blood, 116(21), 1042-1042
Zwaginga, J J, van der Holt, R, Biemond, B J, Boekhorst, P A W, Levin, M, Vreughdenhil, A, Huijgens, P C, Brand, A, van der Griend, R, Luten, M, Pruijt, H, de Weerdt, O, van Pampus, E, Zweegman, S, Hollestein, R & Koene, H R 2010, ' Interim Analysis on a Dutch HOVON Multicenter Randomized Open Label Phase II Trial on 3 Rituximab Dosing Schemes In Chronic ITP Patients: ' . < http://www.mendeley.com/research/interim-analysis-dutch-hovon-multicenter-randomized-open-label-phase-ii-trial-3-rituximab-dosing-sch >
Zwaginga, J J, van der Holt, R, Biemond, B J, Boekhorst, P A W, Levin, M, Vreughdenhil, A, Huijgens, P C, Brand, A, van der Griend, R, Luten, M, Pruijt, H, de Weerdt, O, van Pampus, E, Zweegman, S, Hollestein, R & Koene, H R 2010, ' Interim Analysis on a Dutch HOVON Multicenter Randomized Open Label Phase II Trial on 3 Rituximab Dosing Schemes In Chronic ITP Patients: ' . < http://www.mendeley.com/research/interim-analysis-dutch-hovon-multicenter-randomized-open-label-phase-ii-trial-3-rituximab-dosing-sch >
Abstract 2514 The overall short term effectivity of Rituximab in the treatment of ITP is reported to be around 50%. In most studies the traditional CD20 dosing scheme of 4 weekly interspaced 375 mg/m2 doses is used although other single-arm studies s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91342096607e19be0be834be6df27b24
http://hdl.handle.net/1887/118378
http://hdl.handle.net/1887/118378
Autor:
Henk M. Lokhorst, Sonja Zweegman, Evelien Kneppers, Tuna Mutis, Monique C. Minnema, Edo Vellenga, Marie José Kersten, Ellen Meijer, Petra Cornelisse, Ronnie van der Holt
Publikováno v:
Blood. 116:3502-3502
Abstract 3502 The phase II HOVON 76 study examined the efficacy and safety of maintenance treatment with lenalidomide 10 mgr daily for 21 days in a 28 day cycle for a maximum of 24 cycles following non T-cell depleted non myeloablative allogeneic ste
Autor:
Pieter Sonneveld, Ruud Delwel, King H. Lam, Jeanette K. Doorduijn, Dries A.H Mulder, Ronnie van der Holt, Bob Löwenberg, Nazik Rayman
Publikováno v:
Blood. 104:3256-3256
Since diffuse large B-cell lymphomas (DLBCL) are biologically and clinically heterogeneous, various attempts have been made to distinguish subtypes of DLBCL. Using gene expression profiling two main subtypes have previously been identified, i.e germi